Abstract:Objective To investigate the values of serum N-terminal pro-B-type natriuretic peptide ( NT-proBNP ) in severity assessment and prognostic prediction in the elderly patients with chronic heart failure.Methods A total of 122 elderly patients with chronic heart failure admitted in our hospital from January 2013 to June 2015 were enrolled into the study.According to New York Heart Association (NYHA) classification, the patients were divided into 3 group, that is, NYHAⅡgroup (n=30), NYHAⅢgroup (n=36), and NYHAⅣgroup (n=56).Another 50 healthy individuals served as normal controls.The patients of NYHAⅣ group were further assigned into death subgroup (n=14) and non-death subgroup (n=42).The relationship of serum NT-proBNP level with left ventricular ejection fraction ( LVEF) and left ventricular end diastolic diameter ( LVEDd) was analyzed.The change of NT-proBNP level was compared among the 3 groups before and in 7 and 14 d after treatment.The serum level of NT-proBNP was monitored during the follow-up of 6 to 12 months.Results With the increase of NYHA classification, the age, LVEDd and NT-proBNP level were increased, while LVEF was decreased in the subjects.Serum NT-proBNP level was positively correlated with LVEDd ( r =0.96, P<0.05) and negatively correlated with LVEF (r=-0.79, P<0.05).The level of NT-proBNP was significantly decreased in the patients from the 3 groups in 7 d after treatment ( P<0.05) , and further reduced after 14 days’ treatment, but significant difference was only found in NYHAⅢgroup and NYHAⅣnon-death subgroup between the levels of 2 time points (P<0.05).Compared with the non-death subgroup, the level was remarkably higher in the death subgroup before, in 7 d after treatment and at the last time of detection (P<0.05).In the non-death subgroup, the level was in a trend of reducing (P<0.05).But in the death subgroup, there was no statistical difference in the level before and in 7 d after treatment ( P>0.05) , and the level was also higher at the last time of detection ( P<0.05 ) .Conclusion NT-proBNP is closely associated with heart function, and can be regarded as an important indicator in the diagnosis, efficacy evaluation and prognostic prediction for heart failure.

Relationship of Adiponectin in Plasma to Brain Natriuretic Peptide and Left Ventricular Mass Index of Patients with Chronic Heart Failure

Relationship between the extent of coronary artery lesions and plasma brain natriuretic peptide

Differential Diagnoses Value of Plasama Brain Natriuretic in Patients with Acute Heart Failure

The Correlation Of Left Ventricular Remodeling And Plasma Brain Natriuretic Peptide Undergoing Different Reperfusion In Patients With First ST-segment Elevation Acute Anterior Myocardial Infarction 1

BNP levels and its influencing factors in patients with acute coronary syndrome

Effects of Pravastatin on Cardiac Function and Plasma Level of Brain Natriuretic Peptide in Patients with Chronic Heart Failure

Plasma Brain Natriuretic Peptide Levels in the Diagnosis of Heart Failure

Left Ventricular Geometry and the Levels of Plasma B-type Natriuretic Peptide and Serum Procollagen TypeⅢ in Essential Hypertensive Patients

Influencing factors for plasma natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels in senior patients with heart failure

Clinical significance and changes of plasma brain natriuretic peptide level in patients with chronic obstructive pul monary disease under different conditions

Corelation Between Plasma N-terminal ProBNP(NT-proBNP) and Cardiac Dysfunction

Prognostic Potential of B -Type Natriuetic Peptide and Quality of Life in Patients with Chronic Heart Failure

Evaluation of cardiac function of chronic heart failure with sleep apnea by natriuretic peptides

The Relationship of BNP,hs-CRP with Cardiac Function in Patients with Acute Myocardial Infarction

Brain Natriuretic Peptide and Optimal Management of Heart Failure.

Adiponectin is Valuable in the Diagnosis of Acute Heart Failure with Renal Insufficiency.

Increased Plasma Level of Apelin with NYHA Grade II and III but Not IV.

Values of plasma N-terminal pro-B-type natriuretic peptide in severity assessment and prognostic prediction for chronic heart failure in the elderly

The Relationship between Cardiac Hemodynamics and the Level of Plasma NT-proBNP in Patients with Acute Coronary Syndrome

Changes of Plasma Adrenomedullin and Proadrenomedullin N-terminal 20 Peptide Concentrations in Patients with Heart Failure.

Relationship between serum adiponectin and coronary heart disease